CA2112811A1 - Continuous cell line and vaccine against avian coccidia - Google Patents

Continuous cell line and vaccine against avian coccidia

Info

Publication number
CA2112811A1
CA2112811A1 CA002112811A CA2112811A CA2112811A1 CA 2112811 A1 CA2112811 A1 CA 2112811A1 CA 002112811 A CA002112811 A CA 002112811A CA 2112811 A CA2112811 A CA 2112811A CA 2112811 A1 CA2112811 A1 CA 2112811A1
Authority
CA
Canada
Prior art keywords
cell line
continuous cell
vaccine against
against avian
coccidia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002112811A
Other languages
French (fr)
Other versions
CA2112811C (en
Inventor
Robert A. Clare
Patricia Lufburrow
Timothy J. Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Robert A. Clare
Patricia Lufburrow
Timothy J. Miller
Smithkline Beecham Corporation
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert A. Clare, Patricia Lufburrow, Timothy J. Miller, Smithkline Beecham Corporation, Pfizer Inc. filed Critical Robert A. Clare
Publication of CA2112811A1 publication Critical patent/CA2112811A1/en
Application granted granted Critical
Publication of CA2112811C publication Critical patent/CA2112811C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Abstract

A non-lymphoid continuous cell line adapted for propagation of avian coccidia is provided. This cell line is useful for the production of vaccine antigenes for prophylactic treatment of poultry, particularly in a novel vaccine for coccidia.
CA002112811A 1991-07-12 1992-07-10 Continuous cell line and vaccine against avian coccidia Expired - Fee Related CA2112811C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72925691A 1991-07-12 1991-07-12
US07/729,256 1991-07-12
PCT/US1992/005797 WO1993001276A1 (en) 1991-07-12 1992-07-10 Continuous cell line and vaccine against avian coccidia

Publications (2)

Publication Number Publication Date
CA2112811A1 true CA2112811A1 (en) 1993-01-21
CA2112811C CA2112811C (en) 2004-01-13

Family

ID=24930240

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002112811A Expired - Fee Related CA2112811C (en) 1991-07-12 1992-07-10 Continuous cell line and vaccine against avian coccidia

Country Status (10)

Country Link
US (2) US5674484A (en)
EP (1) EP0594743B1 (en)
JP (1) JP3129441B2 (en)
AT (1) ATE184912T1 (en)
CA (1) CA2112811C (en)
DE (1) DE69230037T2 (en)
DK (1) DK0594743T3 (en)
ES (1) ES2137190T3 (en)
GR (1) GR3032204T3 (en)
WO (1) WO1993001276A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2223700C (en) 1995-06-07 2002-05-07 Pfizer Inc. In ovo vaccination against coccidiosis
CA2223699C (en) 1995-06-07 2002-07-02 Pfizer Inc. In ovo vaccination against coccidiosis
CA2213385A1 (en) * 1997-08-20 1999-02-20 Eng-Hong Lee Method of protecting against coccidiosis infections in poultry
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
US6984378B1 (en) 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
US6605460B1 (en) 2000-09-22 2003-08-12 University Of Minnesota Avian pneumovirus vaccine
CN103316371A (en) 2001-08-30 2013-09-25 恩布里克斯公司 Improved method for producing oocysts
FR2836924B1 (en) 2002-03-08 2005-01-14 Vivalis AVIAN CELL LINES USEFUL FOR THE PRODUCTION OF INTEREST SUBSTANCES
CN100528225C (en) * 2002-05-21 2009-08-19 先灵-普劳有限公司 Methods for the in vitro culture of sporozoea species and uses thereof
US7723087B2 (en) 2002-11-12 2010-05-25 The Brigham And Women's Hospital, Inc. Nucleic acid molecules for enhanced production of a bacterial polysaccharide and methods of use thereof
ES2648046T3 (en) 2002-11-12 2017-12-28 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
US7354593B2 (en) 2002-12-09 2008-04-08 Merial Limited Coccidial vaccine and methods of making and using same
WO2004052393A1 (en) * 2002-12-09 2004-06-24 University Of Georgia Research Foundation, Inc. Coccidial vaccine and methods of making and using same
US6977079B2 (en) * 2003-01-17 2005-12-20 Regents Of The University Of Minnesota Avian pneumovirus vaccine
DE602005021873D1 (en) 2004-03-12 2010-07-29 Univ Georgia NEW VACCINE ADJUVANT AND ITS MANUFACTURE AND USE
AU2005236068C1 (en) 2004-04-21 2012-08-30 Beth Israel Deaconess Medical Center, Inc. Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
US7897150B1 (en) * 2007-04-09 2011-03-01 The Ohio State University Canine lymphoma cell line and uses thereof
BRPI0916365A2 (en) 2008-07-21 2018-05-02 Brigham & Womens Hospital Inc methods and compositions related to synthetic beta-1,6 glycosine oligosaccharides
MX2011007732A (en) * 2009-01-22 2011-11-04 Univ Georgia Mycoplasma gallisepticum formulation.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5780325A (en) * 1980-09-05 1982-05-19 Nat Res Dev Coccidial disease vaccine
US4650676A (en) * 1983-08-19 1987-03-17 American Cyanamid Company Antigens and monoclonal antibodies reactive against merozoites of Eimeria spp.
US4710377A (en) * 1983-08-19 1987-12-01 American Cyanamid Company Antigens and monoclonal antibodies reactive against sporozoites of Eimeria spp.
US5187080A (en) * 1984-06-05 1993-02-16 Solvay & Cie S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
US4874705A (en) * 1985-05-16 1989-10-17 Solvay & Cie, S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
US4639372A (en) * 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
US4724145A (en) * 1985-11-18 1988-02-09 Merck & Co., Inc. Eimeria acervulina immunogens
US5028694A (en) * 1985-12-03 1991-07-02 Solvay & Cie, S.A. Antigenic proteins and vaccines containing them for prevention of coccidiosis caused by eimeria Eimeria necatrix and Eimeria tenella
ATE73494T1 (en) * 1985-12-03 1992-03-15 Solvay ANTIGEN PROTEINS AND VACCINES CONTAINING THEM FOR THE PREVENTION OF COCCIDIOSIS.
US4753798A (en) * 1986-06-30 1988-06-28 American Cyanamid Company Methods and compositions for controlling protozoal infections in warm-blooded animals
US4935007A (en) * 1986-08-28 1990-06-19 Eli Lilly And Company Anticoccidial method
NZ232372A (en) * 1989-02-10 1993-04-28 Merck & Co Inc Glycolipid-linked membrane-associated immunogens of eimeria useful in immunising poultry against coccidiosis
WO1992016627A1 (en) * 1991-03-14 1992-10-01 British Technology Group Usa, Inc. Recombinant anticoccidial vaccine
US5403581A (en) * 1991-07-12 1995-04-04 Hoffmann-La Roche Inc. Coccidiosis vaccines

Also Published As

Publication number Publication date
US5674484A (en) 1997-10-07
DE69230037D1 (en) 1999-10-28
DK0594743T3 (en) 1999-12-20
GR3032204T3 (en) 2000-04-27
JP3129441B2 (en) 2001-01-29
EP0594743B1 (en) 1999-09-22
EP0594743A1 (en) 1994-05-04
US5846527A (en) 1998-12-08
ES2137190T3 (en) 1999-12-16
JPH07505041A (en) 1995-06-08
EP0594743A4 (en) 1995-01-25
ATE184912T1 (en) 1999-10-15
WO1993001276A1 (en) 1993-01-21
CA2112811C (en) 2004-01-13
DE69230037T2 (en) 2000-01-05

Similar Documents

Publication Publication Date Title
CA2112811A1 (en) Continuous cell line and vaccine against avian coccidia
AU610036B2 (en) Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis inflammation and as immunosuppressants
TW352384B (en) Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
GB9016817D0 (en) Sheets comprising hyaluronic acid,the production and the use of the sheets
AU3432989A (en) Product and method for the treatment of acne etc.
EP0458333A3 (en) Polyisocyanato-isocyanurate, and preparation process and use of the same
AU5229793A (en) Novel extracts of cucurbita sp., process for their preparation and use in medicaments and in cosmetics
AU8304087A (en) Coumarane derivatives, their production and use
ITRM930323A0 (en) APPARATUS AND PROCEDURE TO ELIMINATE THE CURLING EFFECT OF SLICED FOOD PRODUCTS.
AU551859B2 (en) 1,8,9 trihydroxyanthracene in form of shampoo
CA2016575A1 (en) Method of aiding cessation of smoking
USD278411S (en) Bottle
CA2068630A1 (en) Use of protein c or activated protein c
USD284942S (en) Bottle of perfume or toilet water
CA2108794A1 (en) Use of torasemide for the treatment of brain oedemas
AU8271191A (en) Indolonaphthyridines, their production and use
GB2216793B (en) Treatment or prophylaxis of acne, dandruff or related conditions
AU4817490A (en) 2',3'-dideoxyribofuranosides and process for producing them
Gates The Female Voice: Sexual Aesthetics Revisited
AU2157688A (en) 1-phenyl substituted-pyrrolidin-2-one and 2-phenyl substituted-4,5,6,7-tetrahydroisoindole-1-one derivatives
AU5461590A (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
SE8804317A (en)
CA2088370A1 (en) New use of monoclonal antibody
AU594806B2 (en) Benzothiazolones, and their production and use
CA2088588A1 (en) Treatment of hair loss and dermatological problems

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed